Detalhe da pesquisa
1.
A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults.
J Clin Invest
; 134(7)2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290009